These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17119927)

  • 1. Open channel block of Kv1.3 by rosiglitazone and troglitazone: Kv1.3 as the pharmacological target for rosiglitazone.
    Ahn HS; Kim SE; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Kim SY; Hahn SJ
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Jan; 374(4):305-9. PubMed ID: 17119927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open channel block of A-type, kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine.
    Kim SE; Ahn HS; Choi BH; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
    J Pharmacol Exp Ther; 2007 May; 321(2):753-62. PubMed ID: 17312186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone inhibits Kv4.3 potassium channels by open-channel block and acceleration of closed-state inactivation.
    Jeong I; Choi BH; Hahn SJ
    Br J Pharmacol; 2011 Jun; 163(3):510-20. PubMed ID: 21232039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv1.3.
    Choi JS; Hahn SJ; Rhie DJ; Yoon SH; Jo YH; Kim MS
    J Pharmacol Exp Ther; 1999 Oct; 291(1):1-6. PubMed ID: 10490879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staurosporine directly blocks Kv1.3 channels expressed in Chinese hamster ovary cells.
    Choi JS; Hahn SJ; Rhie DJ; Jo YH; Kim MS
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):256-61. PubMed ID: 10344523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin-independent inhibition of KV1.3 by FK-506 (tacrolimus): a novel pharmacological property.
    Ahn HS; Kim SE; Choi BH; Choi JS; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Kwon OJ; Hahn SJ
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1714-22. PubMed ID: 17166943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory action of fluvoxamine on Kv1.5 currents.
    Lee HM; Hahn SJ; Choi BH
    Biol Pharm Bull; 2010; 33(6):977-82. PubMed ID: 20522962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dapoxetine on cloned Kv1.5 channels expressed in CHO cells.
    Jeong I; Yoon SH; Hahn SJ
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Jul; 385(7):707-16. PubMed ID: 22538641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct inhibition of the cloned Kv1.5 channel by AG-1478, a tyrosine kinase inhibitor.
    Choi BH; Choi JS; Rhie DJ; Yoon SH; Min DS; Jo YH; Kim MS; Hahn SJ
    Am J Physiol Cell Physiol; 2002 Jun; 282(6):C1461-8. PubMed ID: 11997261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of insulin-sensitizers troglitazone and rosiglitazone on ion currents in rat vascular myocytes.
    Knock GA; Mishra SK; Aaronson PI
    Eur J Pharmacol; 1999 Feb; 368(1):103-9. PubMed ID: 10096775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pergolide block of the cloned Kv1.5 potassium channels.
    Jeong I; Choi BH; Hahn SJ
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Feb; 386(2):125-33. PubMed ID: 22763615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by nystatin of Kv1.3 channels expressed in Chinese hamster ovary cells.
    Hahn SJ; Wang LY; Kaczmarek LK
    Neuropharmacology; 1996; 35(7):895-901. PubMed ID: 8938720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct block by bisindolylmaleimide of rat Kv1.5 expressed in Chinese hamster ovary cells.
    Choi BH; Choi JS; Jeong SW; Hahn SJ; Yoon SH; Jo YH; Kim MS
    J Pharmacol Exp Ther; 2000 May; 293(2):634-40. PubMed ID: 10773038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of lobeline, a nicotinic receptor ligand, on the cloned Kv1.5.
    Jeong I; Choi BH; Hahn SJ
    Pflugers Arch; 2010 Oct; 460(5):851-62. PubMed ID: 20734202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential block by troglitazone and rosiglitazone of glibenclamide-sensitive K(+) current in rat aorta myocytes.
    Mishra SK; Aaronson PI
    Eur J Pharmacol; 1999 Dec; 386(1):121-5. PubMed ID: 10611472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol blocks the cloned cardiac Kv1.5 channels in a β-adrenergic receptor-independent manner.
    Jeong I; Choi BH; Yoon SH; Hahn SJ
    Biochem Pharmacol; 2012 Feb; 83(4):497-505. PubMed ID: 22146582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate and nordihydroguaiaretic acid inhibit human Kv1.5 currents independently of lipoxygenase.
    Gong YZ; Ding WG; Wu J; Tsuji K; Horie M; Matsuura H
    Eur J Pharmacol; 2008 Dec; 600(1-3):18-25. PubMed ID: 18930721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative actions of insulin sensitizers on ion channels in vascular smooth muscle.
    Eto K; Ohya Y; Nakamura Y; Abe I; Fujishima M
    Eur J Pharmacol; 2001 Jun; 423(1):1-7. PubMed ID: 11438300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antidiabetic drug rosiglitazone blocks Kv1.5 potassium channels in an open state.
    Lee HM; Hahn SJ; Choi BH
    Korean J Physiol Pharmacol; 2022 Mar; 26(2):135-144. PubMed ID: 35203063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of mibefradil block of the human heart delayed rectifier hKv1.5.
    Perchenet L; Clément-Chomienne O
    J Pharmacol Exp Ther; 2000 Nov; 295(2):771-8. PubMed ID: 11046117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.